Next Article in Journal
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
Next Article in Special Issue
Future Needs in Mast Cell Biology
Previous Article in Journal
Omega-3 Docosahexaenoic Acid Is a Mediator of Fate-Decision of Adult Neural Stem Cells
Previous Article in Special Issue
Mast Cells May Regulate The Anti-Inflammatory Activity of IL-37
Review

Mast Cell Responses to Viruses and Pathogen Products

1
Dalhousie Human Immunology and Inflammation Group, Department of Microbiology & Immunology, Dalhousie University, Halifax, NS B3H 4H7, Canada
2
Dalhousie Human Immunology and Inflammation Group, Department of Pathology, Dalhousie University, Halifax, NS B3H 4H7, Canada
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(17), 4241; https://doi.org/10.3390/ijms20174241
Received: 23 July 2019 / Revised: 20 August 2019 / Accepted: 26 August 2019 / Published: 30 August 2019
(This article belongs to the Special Issue Mast Cells in Health and Disease)
Mast cells are well accepted as important sentinel cells for host defence against selected pathogens. Their location at mucosal surfaces and ability to mobilize multiple aspects of early immune responses makes them critical contributors to effective immunity in several experimental settings. However, the interactions of mast cells with viruses and pathogen products are complex and can have both detrimental and positive impacts. There is substantial evidence for mast cell mobilization and activation of effector cells and mobilization of dendritic cells following viral challenge. These cells are a major and under-appreciated local source of type I and III interferons following viral challenge. However, mast cells have also been implicated in inappropriate inflammatory responses, long term fibrosis, and vascular leakage associated with viral infections. Progress in combating infection and boosting effective immunity requires a better understanding of mast cell responses to viral infection and the pathogen products and receptors we can employ to modify such responses. In this review, we outline some of the key known responses of mast cells to viral infection and their major responses to pathogen products. We have placed an emphasis on data obtained from human mast cells and aim to provide a framework for considering the complex interactions between mast cells and pathogens with a view to exploiting this knowledge therapeutically. Long-lived resident mast cells and their responses to viruses and pathogen products provide excellent opportunities to modify local immune responses that remain to be fully exploited in cancer immunotherapy, vaccination, and treatment of infectious diseases. View Full-Text
Keywords: mast cell; asthma; infection; interferon; NK cell; chemokine; immunotherapy; oncolytic mast cell; asthma; infection; interferon; NK cell; chemokine; immunotherapy; oncolytic
Show Figures

Figure 1

MDPI and ACS Style

Marshall, J.S.; Portales-Cervantes, L.; Leong, E. Mast Cell Responses to Viruses and Pathogen Products. Int. J. Mol. Sci. 2019, 20, 4241. https://doi.org/10.3390/ijms20174241

AMA Style

Marshall JS, Portales-Cervantes L, Leong E. Mast Cell Responses to Viruses and Pathogen Products. International Journal of Molecular Sciences. 2019; 20(17):4241. https://doi.org/10.3390/ijms20174241

Chicago/Turabian Style

Marshall, Jean S., Liliana Portales-Cervantes, and Edwin Leong. 2019. "Mast Cell Responses to Viruses and Pathogen Products" International Journal of Molecular Sciences 20, no. 17: 4241. https://doi.org/10.3390/ijms20174241

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop